Safety and long-term efficacy of autologous hematopoietic cell transplantation for patients with systemic sclerosis

Autologous hematopoietic cell transplantation (HCT) has been introduced for patients with severe systemic sclerosis (SSc). We aimed to assess the safety and long-term efficacy of HCT modality for severe SSc, refractory to conventional therapy, in 17 patients who were referred to our – The Joint Accr...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Eleni Gavriilaki, Despina Mallouri, Ioannis Batsis, Zoi Bousiou, Anna Vardi, Nikolaos Spyridis, Georgios Karavalakis, Alkistis kyra Panteliadou, Panagiotis Dolgyras, Christos Varelas, Vlasios I. Alevizopoulos, Panagiotis G. Asteris, Panayiotis Vlachoyiannopoulos, Damianos Sotiropoulos, Petros P. Sfikakis, Ioanna Sakellari
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2025-07-01
coleção:	Frontiers in Medicine
Assuntos:	cell therapy hematopoietic cell transplantation systemic sclerosis scleroderma treatment-related mortality
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1527779/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!